Financial statements Emes Laboratorium
Balance sheet data of EMES LABORATORIUM
|
Year
|
2021
|
2023
|
|---|---|---|
| Total assets | 6 344 030,55 | 5 041 880,96 |
| A. Fixed assets | 5 607 724,76 | 4 636 763,80 |
| B. Current assets | 736 305,79 | 405 117,16 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 6 344 030,55 | 5 041 880,96 |
| A. Equity | -1 136 026,97 | -2 972 335,53 |
| B. Liabilities and provisions for liabilities | 7 480 057,52 | 8 014 216,49 |
| I. Long-term liabilities | 7 251 003,27 | 7 833 471,76 |
| II. Short-term liabilities | 228 218,39 | 135 136,73 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.